Titan Medical Inc. (TMD.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
As of 09:30AM EST. Market open.
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 102.05M |
| Enterprise Value | 50.00M |
| Trailing P/E | 26.54 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.66 |
| Price/Book (mrq) | 3.17 |
| Enterprise Value/Revenue | 2.49 |
| Enterprise Value/EBITDA | -0.97 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 4.72 |
| 52-Week Change 3 | -81.61% |
| S&P500 52-Week Change 3 | 14.56% |
| 52 Week High 3 | 4.3600 |
| 52 Week Low 3 | 0.6400 |
| 50-Day Moving Average 3 | 0.9050 |
| 200-Day Moving Average 3 | 1.7626 |
Share Statistics
| Avg Vol (3 month) 3 | 71.1k |
| Avg Vol (10 day) 3 | 26.82k |
| Shares Outstanding 5 | 110.93M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 111.05M |
| % Held by Insiders 1 | 0.22% |
| % Held by Institutions 1 | 4.53% |
| Shares Short (Jan. 13, 2022) 4 | 175.71k |
| Short Ratio (Jan. 13, 2022) 4 | 2.73 |
| Short % of Float (Jan. 13, 2022) 4 | 0.16% |
| Short % of Shares Outstanding (Jan. 13, 2022) 4 | 0.16% |
| Shares Short (prior month Dec. 14, 2021) 4 | 144.16k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jun. 18, 2018 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:30 |
| Last Split Date 3 | Jun. 18, 2018 |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | -223.57% |
| Operating Margin (ttm) | -123.10% |
Management Effectiveness
| Return on Assets (ttm) | -39.51% |
| Return on Equity (ttm) | -308.06% |
Income Statement
| Revenue (ttm) | 20.09M |
| Revenue Per Share (ttm) | 0.20 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 20M |
| EBITDA | -24.45M |
| Net Income Avi to Common (ttm) | -44.92M |
| Diluted EPS (ttm) | -0.5620 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 44.68M |
| Total Cash Per Share (mrq) | 0.4 |
| Total Debt (mrq) | 3.54M |
| Total Debt/Equity (mrq) | 13.91 |
| Current Ratio (mrq) | 1.97 |
| Book Value Per Share (mrq) | 0.23 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24.33M |
| Levered Free Cash Flow (ttm) | -14.22M |
